Oliveira S F, Jatene A D, Solimene M C, de Oliveira S A, Meneguetti C, Jatene F B, Stolf N G, Pileggi F, Ramires J A
Heart Institute, Hospital das Clínicas, Medical School, University of São Paulo, SP, Brazil.
Heart Surg Forum. 1999;2(1):47-53.
We evaluated the prognostic value of preoperative parameters, surgical risk, functional benefits and long-term survival after myocardial revascularization in patients with established ischemic cardiomyopathy.
Seventy-one patients with ischemic cardiomyopathy, severe left ventricular dysfunction (left ventricular ejection fraction < 30%), and myocardial perfusion evaluated by Thallium-201 scintigraphy, were studied before and after myocardial revascularization, during hospitalization and throughout 48 months (average) of late follow-up.
The early postoperative mortality was 2.8% and the five-year survival rate was 62.8%. When the survival rate was studied, there was no correlation with 1) the presence of Q-waves on preoperative cardiogram, 2) the presence of ischemia on Tl-201 scintigraphy, 3) the degree of left ventricular ejection fraction, or 4) the presence of angina. There was a statistically significant difference for survivors and non-survivors in the following parameters: 1) functional class IV of CHF, and 2) the presence of left bundle-branch block (LBBB).
Our surgical results confirm that myocardial revascularization is a safe procedure, and that it increases late survival and improves the quality of life in patients with ischemic cardiomyopathy and severe left ventricular dysfunction. We also observed that due to heterogeneous coronary and myocardial patterns of ischemic cardiomyopathy, preoperative prognostic parameters are difficult to establish. Preoperative functional class IV congestive heart failure, and LBBB were the main predictors of poor outcome following surgical revascularization for ischemic cardiomyopathy.
我们评估了已确诊的缺血性心肌病患者心肌血运重建术后术前参数、手术风险、功能获益及长期生存的预后价值。
对71例缺血性心肌病、严重左心室功能不全(左心室射血分数<30%)且通过铊-201心肌显像评估心肌灌注的患者,在心肌血运重建术前、术后住院期间及整个48个月(平均)的后期随访中进行研究。
术后早期死亡率为2.8%,五年生存率为62.8%。在研究生存率时,其与以下因素无相关性:1)术前心电图上Q波的存在;2)铊-201心肌显像上缺血的存在;3)左心室射血分数的程度;4)心绞痛的存在。在以下参数方面,存活者与非存活者存在统计学显著差异:1)CHF的功能分级IV级;2)左束支传导阻滞(LBBB)的存在。
我们的手术结果证实,心肌血运重建是一种安全的手术,可提高缺血性心肌病和严重左心室功能不全患者的后期生存率并改善生活质量。我们还观察到,由于缺血性心肌病的冠状动脉和心肌模式存在异质性,术前预后参数难以确定。术前充血性心力衰竭功能分级IV级和LBBB是缺血性心肌病手术血运重建后预后不良的主要预测因素。